Chemo patch for skin cancer shows promise in early trial
NCT ID NCT03646188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new way to deliver the chemotherapy drug doxorubicin directly into basal cell skin cancer using tiny dissolving needles on a patch. The goal was to find a safe dose and see if it could completely remove the cancer. The study included 13 adults with small, untreated skin cancers, but was stopped early.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Center for Clinical and Cosmetic Research
Aventura, Florida, 33180, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Botox before the knife: could a Pre-Surgery injection lead to Better-Looking scars?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New skin patch could speed recovery after skin cancer removal
- AI reads skin lesions to predict cancer aggressiveness
- Needle-Free light therapy shows promise for common skin cancer
- Snap and measure: new photo method tracks nose shape after skin cancer surgery